三友医疗某实控人拟减持 完成关联收购去年扣非亏损

Core Viewpoint - David Fan, a significant shareholder and executive of Sanyou Medical, plans to reduce his stake by up to 4,000,000 shares, approximately 1.44% of the total shares, due to personal financial needs [1] Company Performance - In 2024, the company reported a revenue of 454 million yuan, a year-on-year decrease of 1.48%, and a net profit attributable to shareholders of 11.47 million yuan, down 88.00% [2] - The company's cash flow from operating activities was 10.96 million yuan, a decline of 95.90% compared to the previous year [2] - For Q1 2025, the company achieved a revenue of 116 million yuan, a year-on-year increase of 34.72%, and a net profit of 12.82 million yuan, marking a return to profitability [2] Shareholding Structure - As of the disclosure date in 2024, the total share capital of the company was 277,885,415 shares, with Xu Nong holding 11.78%, Chaos Tiancheng 2.66%, Michael Mingyan Liu 9.10%, and David Fan 6.25%, collectively controlling 29.80% of the shares [3] - The actual controllers of the company are Xu Nong, Michael Mingyan Liu, and David Fan, who have formed a concerted action relationship [2][3] Fundraising and Financial Transactions - Sanyou Medical raised a total of 1.076 billion yuan through its IPO, with a net fundraising amount of 978 million yuan, exceeding the original plan by 378 million yuan [4] - The company plans to use the raised funds for orthopedic implant expansion, product development, marketing network construction, and working capital [4] - The company completed a transaction to acquire a 37.1077% stake in Waterwood Tianpeng for 330.92 million yuan and 100% of Shanghai Hanzhan for 84.76 million yuan [6][7]